中医药防治结直肠腺瘤的表观遗传机制研究 进展
Research Progress on the Epigenetic Mechanism of Traditional Chinese Medicine in the Prevention and Treatment of Colorectal Adenomas
摘要: 结直肠腺瘤作为结直肠癌明确的癌前病变,其防治是降低结直肠癌发病率的關鍵环节。中医药基于“治未病”思想,认为“脾虚”是其核心病机,“健脾固本”是重要的干预原则。近年来,表观遗传学研究揭示,在腺瘤向癌演变过程中,由DNA甲基化、组蛋白修饰等异常构成的“表观遗传微环境”紊乱起着关键的驱动作用,这为阐释“健脾固本”的生物学内涵提供了全新的分子视角。本综述系统梳理了中医药通过“健脾固本”干预结直肠腺瘤的研究现状,重点聚焦于健脾类中药复方及单体成分通过调控DNA甲基化、组蛋白修饰、非编码RNA等表观遗传机制,重塑肿瘤微环境、逆转细胞恶性潜能、从而抑制腺瘤发生发展的最新进展。同时,探讨了类器官等前沿模型在“病证结合”机制研究中的应用,并分析了当前面临的挑战与未来发展方向,旨在为中医药现代化防治结直肠腺瘤提供理论参考与研究思路。
Abstract: Colorectal adenomas, as definite precancerous lesions of colorectal cancer, are crucial for the prevention and treatment of colorectal cancer. Based on the concept of “preventing disease before it occurs”, traditional Chinese medicine believes that “spleen deficiency” is the core pathogenesis, and “strengthening the spleen and consolidating the foundation” is an important intervention principle. In recent years, epigenetic research has revealed that during the transformation from adenomas to cancer, the disorder of the “epigenetic microenvironment” composed of abnormal DNA methylation, histone modifications, etc., plays a key driving role. This provides a new molecular perspective for explaining the biological connotation of “strengthening the spleen and consolidating the foundation”. This review systematically summarizes the current research status of traditional Chinese medicine’s intervention on colorectal adenomas through “strengthening the spleen and consolidating the foundation”, focusing on the latest progress of strengthening-treating-type Chinese medicine compound prescriptions and single components that regulate epigenetic mechanisms such as DNA methylation, histone modification, and non-coding RNA to reshape the tumor microenvironment, reverse the malignant potential of cells, and thereby inhibit the occurrence and development of adenomas. At the same time, it discusses the application of advanced models such as organoids in the study of the “disease-syndrome combination” mechanism, and analyzes the current challenges and future development directions, aiming to provide theoretical references and research ideas for the modernization of traditional Chinese medicine in the prevention and treatment of colorectal adenomas.
文章引用:林琳, 张洁, 黄国欣, 魏泽辉, 王星儒, 许秋苗. 中医药防治结直肠腺瘤的表观遗传机制研究 进展[J]. 临床医学进展, 2026, 16(3): 3608-3613. https://doi.org/10.12677/acm.2026.1631168

参考文献

[1] Shi, C., Li, S., Shen, C., Pan, F., Deng, L., Fu, W., et al. (2022) Icariside II Suppressed Tumorigenesis by Epigenetically Regulating the Circβ-Catenin-Wnt/β-Catenin Axis in Colorectal Cancer. Bioorganic Chemistry, 124, Article ID: 105800. [Google Scholar] [CrossRef] [PubMed]
[2] Lin, J., Zhang, L., Chen, M., Chen, J., Wu, Y., Wang, T., et al. (2022) Evaluation of Combined Detection of Multigene Mutation and SDC2/SFRP2 Methylation in Stool Specimens for Colorectal Cancer Early Diagnosis. International Journal of Colorectal Disease, 37, 1231-1238. [Google Scholar] [CrossRef] [PubMed]
[3] Sun, D., Zou, Y., Song, L., Han, S., Yang, H., Chu, D., et al. (2022) A Cyclodextrin-Based Nanoformulation Achieves Co-Delivery of Ginsenoside Rg3 and Quercetin for Chemo-Immunotherapy in Colorectal Cancer. Acta Pharmaceutica Sinica B, 12, 378-393. [Google Scholar] [CrossRef] [PubMed]
[4] Liang, J., Yang, C., Li, P., Zhang, M., Xie, X., Xie, X., et al. (2023) Astragaloside IV Inhibits AOM/DSS-Induced Colitis-Associated Tumorigenesis via Activation of PPARγ Signaling in Mice. Phytomedicine, 121, Article ID: 155116. [Google Scholar] [CrossRef] [PubMed]
[5] Yildiz, B., Demirel, R., Staudacher, J.J., Beseren, H., Yildiz, G., Akpinar, A.E., et al. (2024) SIRT2 Deacetylates and Decreases the Expression of FOXM1 in Colon Cancer. Journal of Biochemical and Molecular Toxicology, 38, e70018. [Google Scholar] [CrossRef] [PubMed]
[6] Wang, S., Xie, M., Sun, K., Deng, W., et al. (2023) Effect of Shenling Baizhu Powder on Intestinal Mucosal Barrier in Mice with Xenograft Model of Colorectal Cancer after Chemotherapy. Shanghai Journal of Traditional Chinese Medicine, 57, 57-64.
[7] Shang, L., Wang, Y., Li, J., Zhou, F., Xiao, K., Liu, Y., et al. (2023) Mechanism of Sijunzi Decoction in the Treatment of Colorectal Cancer Based on Network Pharmacology and Experimental Validation. Journal of Ethnopharmacology, 302, Article ID: 115876. [Google Scholar] [CrossRef] [PubMed]
[8] Sadoughi, F., Maleki Dana, P., Asemi, Z. and Yousefi, B. (2021) Targeting MicroRNAs by Curcumin: Implication for Cancer Therapy. Critical Reviews in Food Science and Nutrition, 62, 7718-7729. [Google Scholar] [CrossRef] [PubMed]
[9] Fang, Y., Yan, C., Zhao, Q., Xu, J., Liu, Z., Gao, J., et al. (2021) The Roles of Microbial Products in the Development of Colorectal Cancer: A Review. Bioengineered, 12, 720-735. [Google Scholar] [CrossRef] [PubMed]
[10] Xie, K., Ouyang, Y., Wang, Y. and Li, C. (2026) Thoughts on the Scientific Research of the Connotation of Traditional Chinese Medicine Patterns. Journal of Traditional Chinese Medical Sciences, 13, 3-11. [Google Scholar] [CrossRef